These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 3760058)
1. Determination of 2-mercaptopropionylglycine in plasma and urine by high-performance liquid chromatography. Kågedal B; Carlsson M; Denneberg T J Chromatogr; 1986 Aug; 380(2):301-11. PubMed ID: 3760058 [TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of tiopronin and its primary metabolite in plasma and ocular tissues by HPLC. Beltz J; Pfaff A; Ercal N Biomed Chromatogr; 2019 Feb; 33(2):e4375. PubMed ID: 30176059 [TBL] [Abstract][Full Text] [Related]
4. Fully automated assay for total homocysteine, cysteine, cysteinylglycine, glutathione, cysteamine, and 2-mercaptopropionylglycine in plasma and urine. Pastore A; Massoud R; Motti C; Lo Russo A; Fucci G; Cortese C; Federici G Clin Chem; 1998 Apr; 44(4):825-32. PubMed ID: 9554495 [TBL] [Abstract][Full Text] [Related]
5. Comparison of 2-mercaptopropionylglycine and D-penicillamine in the treatment of cystinuria. Harbar JA; Cusworth DC; Lawes LC; Wrong OM J Urol; 1986 Jul; 136(1):146-9. PubMed ID: 3712602 [TBL] [Abstract][Full Text] [Related]
6. Determination of 2-mercaptopropionylglycine and its metabolite, 2-mercaptopropionic acid, in plasma by ion-pair reversed-phase high-performance liquid chromatography with post-column derivatization. Leroy P; Nicolas A; Gavriloff C; Matt M; Netter P; Bannwarth B; Hercelin B; Mazza M J Chromatogr; 1991 Mar; 564(1):258-65. PubMed ID: 1860918 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intravenous 2-mercaptopropionylglycine in man. Carlsson SM; Denneberg T; Emanuelsson BM; Kågedal B; Lindgren S Eur J Clin Pharmacol; 1990; 38(5):499-503. PubMed ID: 2379536 [TBL] [Abstract][Full Text] [Related]
8. Canine cystinuria: an extended study on the effects of 2-mercaptopropionylglycine on cystine urolithiasis and urinary cystine excretion. Hoppe A; Denneberg T; Jeppsson JO; Kågedal B Br Vet J; 1993; 149(3):235-51. PubMed ID: 8334506 [TBL] [Abstract][Full Text] [Related]
9. [Colorimetric analysis of mercaptopropionylglycine in pharmaceutic formulations]. Raggi MA; Cesaroni MR; Di Pietra AM Farmaco Prat; 1983 Aug; 38(8):312-6. PubMed ID: 6617831 [No Abstract] [Full Text] [Related]
10. High-performance liquid chromatography of 2-mercaptopropionylglycine and its metabolite 2-mercaptopropionic acid in plasma and urine after treatment with thiopronine. Kågedal B; Andersson T; Carlsson M; Denneberg T; Hoppe A J Chromatogr; 1987 Jul; 417(2):261-7. PubMed ID: 3654879 [TBL] [Abstract][Full Text] [Related]
11. Cysteinylglycine in urine determined by high-performance liquid chromatography. Kågedal B; Källberg M J Chromatogr; 1984 Jun; 308():75-82. PubMed ID: 6746837 [TBL] [Abstract][Full Text] [Related]
12. Colorimetric determination of acetylcysteine, penicillamine, and mercaptopropionylglycine in pharmaceutical dosage forms. Raggi MA; Cavrini V; Di Pietra AM J Pharm Sci; 1982 Dec; 71(12):1384-6. PubMed ID: 7153888 [TBL] [Abstract][Full Text] [Related]
13. Determination of captopril and its mixed disulphides in plasma and urine by high-performance liquid chromatography. Hayashi K; Miyamoto M; Sekine Y J Chromatogr; 1985 Feb; 338(1):161-9. PubMed ID: 3894398 [TBL] [Abstract][Full Text] [Related]
14. [Effect of alpha-mercaptopropionylglycine (alpha-MPG) and sodium dipropylacetate (DPA) on antibody formation (IV). Tumor immunity (author's transl)]. Mori H; Saiki I; Koda A Nihon Yakurigaku Zasshi; 1978 Nov; 74(8):907-23. PubMed ID: 374206 [TBL] [Abstract][Full Text] [Related]
15. Determination of dopamine-3- and 4-O-sulphate in human plasma and urine by anion-exchange high-performance liquid chromatography with fluorimetric detection. Yamamoto T; Yamatodani A; Nishimura M; Wada H J Chromatogr; 1985 Aug; 342(2):261-7. PubMed ID: 4055948 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of 2-(alpha-thenoylthio)-propionylglycine (TTPG) in healthy volunteers--an oral dose-proportionality investigation. Marzo A; Bruno G; Nava D; Giubilei C; Arrigoni Martelli E; Douin MJ; Chassard D; Mignot A; Thebault JJ J Pharm Biomed Anal; 1992 Sep; 10(9):623-9. PubMed ID: 1286128 [TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of metals during treatment with D-penicillamine and 2-mercaptopropionylglycine in normal and cystinuric dogs. Hoppe A; Denneberg T; Frank A; Kågedals B; Petersson LR J Vet Pharmacol Ther; 1993 Mar; 16(1):93-102. PubMed ID: 8479006 [TBL] [Abstract][Full Text] [Related]
18. Reversed-phase ion-pair high-performance liquid chromatography of mercaptoacetate and N-acetylcysteine after derivatization with N-(1-pyrene)maleimide and N-(7-dimethylamino-4-methyl-3-coumarinyl)maleimide. Kågedal B; Källberg M J Chromatogr; 1982 May; 229(2):409-15. PubMed ID: 7096475 [TBL] [Abstract][Full Text] [Related]
19. High-performance liquid chromatographic determination of total plasma homocysteine with or without internal standards. Accinni R; Campolo J; Bartesaghi S; De Leo G; Lucarelli C; Cursano CF; Parodi O J Chromatogr A; 1998 Dec; 828(1-2):397-400. PubMed ID: 9916320 [TBL] [Abstract][Full Text] [Related]
20. Radiation protection of pronormoblasts and normoblasts by 2-mercaptopropionylglycine (MPG). Saini MR; Devi PU Experientia; 1980 Apr; 36(4):448-9. PubMed ID: 7379921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]